Albion Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76K | Hold |
3,043
| – | – | ﹤0.01% | 461 |
|
|
2025
Q1 | $1.38K | Hold |
3,043
| – | – | ﹤0.01% | 510 |
|
|
2024
Q4 | $1.53K | Hold |
3,043
| – | – | ﹤0.01% | 572 |
|
|
2024
Q3 | $2.76K | Hold |
3,043
| – | – | ﹤0.01% | 408 |
|
|
2024
Q2 | $3.04K | Hold |
3,043
| – | – | ﹤0.01% | 402 |
|
|
2024
Q1 | $4.5K | Hold |
3,043
| – | – | ﹤0.01% | 362 |
|
|
2023
Q4 | $3.32K | Hold |
3,043
| – | – | ﹤0.01% | 370 |
|
|
2023
Q3 | $3.59K | Hold |
3,043
| – | – | ﹤0.01% | 346 |
|
|
2023
Q2 | $4.29K | Hold |
3,043
| – | – | ﹤0.01% | 343 |
|
|
2023
Q1 | $4.57K | Hold |
3,043
| – | – | ﹤0.01% | 339 |
|
|
2022
Q4 | $3.56K | Hold |
3,043
| – | – | ﹤0.01% | 353 |
|
|
2022
Q3 | $3K | Hold |
3,043
| – | – | ﹤0.01% | 373 |
|
|
2022
Q2 | $5K | Hold |
3,043
| – | – | ﹤0.01% | 356 |
|
|
2022
Q1 | $5K | Hold |
3,043
| – | – | ﹤0.01% | 413 |
|
|
2021
Q4 | $7K | Hold |
3,043
| – | – | ﹤0.01% | 429 |
|
|
2021
Q3 | $8K | Hold |
3,043
| – | – | ﹤0.01% | 392 |
|
|
2021
Q2 | $9K | Buy |
+3,043
| New | +$9K | ﹤0.01% | 381 |
|
|
2020
Q4 | $5K | Buy |
+3,043
| New | +$5K | ﹤0.01% | 383 |
|
|
2015
Q4 | – | Sell |
-28,603
| Closed | -$69K | – | 176 |
|
|
2015
Q3 | $69K | Hold |
28,603
| – | – | 0.01% | 175 |
|
|
2015
Q2 | $84K | Hold |
28,603
| – | – | 0.01% | 180 |
|
|
2015
Q1 | $115K | Hold |
28,603
| – | – | 0.02% | 173 |
|
|
2014
Q4 | $86K | Hold |
28,603
| – | – | 0.01% | 174 |
|
|
2014
Q3 | $72K | Hold |
28,603
| – | – | 0.01% | 177 |
|
|
2014
Q2 | $70K | Hold |
28,603
| – | – | 0.01% | 188 |
|
|
2014
Q1 | $76K | Hold |
28,603
| – | – | 0.01% | 185 |
|
|
2013
Q4 | $83K | Hold |
28,603
| – | – | 0.02% | 168 |
|
|
2013
Q3 | $88K | Hold |
28,603
| – | – | 0.02% | 168 |
|
|
2013
Q2 | $91K | Buy |
+28,603
| New | +$91K | 0.02% | 154 |
|